VISTA, Calif.--(BUSINESS WIRE)--Aperio Technologies, Inc., (Aperio), the global leader in digital pathology for the healthcare and life sciences industry, is pleased to announce that it has secured an exclusive worldwide license from Los Alamos National Laboratory (LANL) for the use of LANL’s Genetic Imagery Exploration (Genie Pro) image pattern recognition technology in the digital pathology market.
